Emerging treatments for age-related macular degeneration

  • 20 September 2017
  • Volume 18, Issue 3

This narrative review summarises emerging interventions that may be mentioned in the popular and professional press, and may be on our menu of treatment options to discuss with patients in the near future.

Share options

Introduction

When optometry and medical students are taught at university, a dramatic caveat should be added to much of what they learn: that it will be of no use in their careers to come. Knowledge is constantly replaced or updated, and clinical skills are at risk of being superseded by technology: for example, the time-honoured art of direct ophthalmoscopy may be on the verge of redundancy (Purbrick and Chong 2015). Age-related macular degeneration (AMD) is the commonest cause of visual impairment in the western world, and is becoming an increasing public health challenge in Asia (Velez-Montoya et al. 2014). The management of AMD underwent a paradigm shift in 2006 with the advent of antivascular endothelial growth factor treatments (anti-VEGFs) and optical coherence tomography (OCT).

Login or join the College to read more and take the CET quiz.

Login Required

Not yet a member of the College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

More on

Read next

CET 1
18 November 2014 Optometry in Practice

Age-related macular degeneration: the optometrist's role in detection and management

The role of optometrist in the detection and management of AMD in the UK and Australia.

21 November 2011 Optometry in Practice

Online AMD research study for optometrists: current practice in Ireland and UK

Investigating current practice for managing and treating AMD in Ireland and the UK.

AMD
OK
Loading...
Loading...
Loading...